Enhanced Capital Group

Enhanced Capital Group is a prominent private investment firm focused on impact investing, small business lending, and community development. Founded in 1999, the firm provides diversified financing solutions, including tax credit equity and debt capital to businesses and projects in underserved markets. While not a biotechnology developer itself, Enhanced Capital is a significant financier within the healthcare and life sciences sectors, supporting medical technology companies, healthcare providers, and research facilities. In 2021, the firm was acquired by P10, Inc., a leading multi-asset class private markets solution provider, where it continues to operate as a specialized investment platform.